Abstract
Simple SummaryCancer cells require amino acids to grow and survive. Amino acid starvation inhibits cancer growth. This study investigates why the non-essential amino acid asparagine is important for cancer growth by examining metabolite composition in asparagine-deprived sarcoma cells compared to control cells with normal asparagine access. Our experiments show that asparagine deprivation results in an imbalance between certain antioxidants and free radicals in the cell. Chemicals which impair the regeneration of antioxidants in the cell augment the growth inhibition caused by asparagine starvation.Amino acids are integral components of cancer metabolism. The non-essential amino acid asparagine supports the growth and survival of various cancer cell types. Here, different mass spectrometry approaches were employed to identify lower aspartate levels, higher aspartate/glutamine ratios and lower tricarboxylic acid (TCA) cycle metabolite levels in asparagine-deprived sarcoma cells. Reduced nicotinamide adenine dinucleotide (NAD+)/nicotinamide adenine dinucleotide hydride (NADH) ratios were consistent with redirection of TCA cycle flux and relative electron acceptor deficiency. Elevated lactate/pyruvate ratios may be due to compensatory NAD+ regeneration through increased pyruvate to lactate conversion by lactate dehydrogenase. Supplementation with exogenous pyruvate, which serves as an electron acceptor, restored aspartate levels, NAD+/NADH ratios, lactate/pyruvate ratios and cell growth in asparagine-deprived cells. Chemicals disrupting NAD+ regeneration in the electron transport chain further enhanced the anti-proliferative and pro-apoptotic effects of asparagine depletion. We speculate that reductive stress may be a major contributor to the growth arrest observed in asparagine-starved cells.
Highlights
Amino acids are integral components of cancer cell metabolism
Intracellular asparagine content in A-N0 cells was reduced to
Asparagine does not serve as an intermediary metabolite, but it still assumes an important role in sarcoma metabolism
Summary
The KRAS-driven mouse sarcoma cell line used in this study was established from a genetically engineered Kras(G12v);p16p19null mouse sarcoma with myogenic differentiation [3,12]. The human embryonal rhabdomyosarcoma cell line RD was purchased from American Type Culture Collection (ATCC). Both cell lines were kept in DMEM with. 4.15 g DMEM (D5030, Sigma Aldrich), 1.85 g NaHCO3 (Sigma Aldrich), 10% FBS and 1% PS were reconstituted in 500 mL dH2O together with defined amounts of glutamine (0 to 292 mg; Sigma), glucose (0.25 to 2.25 g; Sigma Aldrich) and asparagine (0 to 50 mg; A4159, Sigma Aldrich). Short tandem repeat analyses of mouse (Table S7) and human (Table S8) cell lines used in this study were performed by Eurofins
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.